, Probably the most important of all anaerobes based on
likelihood of clinical conditions, as well as
its resistance to many antibiotics. Bacteriodes classified as fragile >> << gram-negative bacterium Bacillus exhibition rounded ends and usually
encapsulation. Review: Gram-negative aerobic bacteria
responsible for many kinds of infections from oral to a bone infection. Pathological manifestations >> << include >> << involved in pathological processes such as periodontal disease and colon cancer
. Gram-negative bacteria release enzymes such as neuraminidase and
kollahenaza that facilitate the body's tissues
penetration. Anaerobic infections include: bite infections
mouth or tooth infections, empyema, lung abscess, aspiration pneumonia
after abortion infection, appendicitis, diverticulitis
septic thrombophlebitis, sepsis and that
may be associated with diabetes, cancer, negative culture >> << blood and corticosteroids. Sidney M. Faynhold
, Anaerobic gram-negative rods in medical microbiology (4
edition), edited by Samuel Baron, MD, University of Texas Medical Branch
pneumonia Serratia (, left)
image credit: Shirley Owens and Catherine McGowan, microbe zoo
Project, Memory Tech Lab, University of Michigan. Serratia (b, right)
EUROMECH 422 structures formation by swimming microorganisms in clinical laboratories >> <<, E.coli (Escherichia coli) is probably the most frequently isolated organism
. E.coli is a member of the group
called E. coli pathogens, including those families
coli, Enterobacter, Citrobacter, Klebsiella, Serratia and. In addition, Proteus is a member of this group. Many of these organisms
usually found in the gastrointestinal tract, thereby
considered normal flora. Intestinal infections - E. coli is a major cause >> << to infections, especially in developing countries
, both major enteric (intestinal) pathogen. Intrahospital infections (hospital acquired infection
), often (frequency = 29% in the United
, United States) in connection with koliformnyh bacteria and Proteus. These organisms
often responsible for urinary tract infections
(46%) and infections associated with surgical site
(24%). E. coli is the most well-known nosocomial pathogen
. Community Infections: As mentioned above, for nosocomial infections come coli
is known as a cause of urinary tract infection is in the
outpatient environment. Urinary tract infections
include prostatitis, pyelonephritis. Other common pathogens include Proteus urinary tract infection
in Klebsiella and Enterobacter
Proteus Mirabilis is the most likely cause of infection related
kidney stones. Klebsiella pneumonia causes severe pneumonia. 2 M strattera. Neal Buentzel coli,
. Klebsiella, Enterobacter, Serratia, Citrobacter, Proteus and
Medical Microbiology (fourth edition), edited by Samuel Baron, MD,
University of Texas Medical Branch, Moraxella
cattarrhalis,
Gram-negative bacteria often found in normal >> << human upper respiratory tract flora, similar in appearance
Neisseria cells. Sometimes, Moraxella cattarrhalis May
cause significant lung disease such as pneumonia and acute bronchitis >> << and important systemic infections, including meningitis and endocarditis
. In both children and adults, the body
be generally responsible for otitis media, sinusitis, conjunctivitis and
. (Moraxella cattarrhalis may cause more than 20%
otitis media presentation)
Moraxella cattarrhalis may be responsible for
infection of lower respiratory tract of adults with chronic diseases
lungs. This organism is often found in normal flora
and children (frequency = 40% -50%). Moraxella cattarrhalis can cause symptoms that
very similar, almost indistinguishable from those caused by
gonococci as differential rating
quite important. In addition, many strains of Moraxella cattarrhalis
complex beta-lactamase resistance makes them too much beta-lactam antibiotics.
Steven Morse Neisseria,
Moraxella, Kingella and Eikenella in
Medical Microbiology (fourth edition), edited by Samuel Baron, MD,
University of Texas Medical Branch
Wolf Washington, Hebhardt BM, ML Hammarskjöld et al, eds. Fundamentals of Medical Microbiology, 5th ed. Philadelphia, Pennsylvania: Lippinkott-Raven, 1996. GlaxoSmithKline, 2001 (Augmentin
use).
No comments:
Post a Comment